Skip to content

Comparative Study of Intraarticular knee injection of corticosteroid with ozone (15 µg/ml) Versus Corticosteroid with Oxygen for the Treatment of Osteoarthritis-related Knee Pain

Comparative Study of Intraarticular knee injection of corticosteroid with ozone (15 µg/ml) Versus Corticosteroid with Oxygen for the Treatment of Osteoarthritis-related Knee Pain

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151017024572N26
Enrollment
36
Registered
2025-10-06
Start date
2025-09-26
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary knee osteoarthrosis,. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: corticosteroid with oxygen injection will be performed under the ultrasound guid in the knee joint which will be done by an experienced physical medicine and rehabi
using supra patellar approach. Intervention 2: Control group: corticosteroid with ozone injection will be performed under the ultrasound guid in the knee joint which will be done by an experienced phy

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Knee osteoarthritis based on the American College of Rheumatology criteria in grade 2 and 3, consistent with the Lawrence–Kellgren criteria. 2. Knee pain for at least six months. 3. Age between 18 and 75 years. 4. Absence of any acute or chronic infection. 5. Not pregnant and not planning pregnancy. 6. No intra-articular knee injection within the past three months. 7. Absence of inflammatory joint diseases or secondary osteoarthritis. 8. No history of knee surgery. 9. No severe underlying diseases such as uncontrolled diabetes, anticoagulant use, etc. 10. No daily use of opioid or non-opioid analgesics.

Exclusion criteria

Exclusion criteria: 1. Patients with major depression or other psychiatric disorders (such as needle phobia, etc.). 2. History of tumor or local infection in the knee area. 3. History of malignancies (multiple myeloma, bone metastases, leukemia, or lymphoma).

Design outcomes

Primary

MeasureTime frame
The severity of pain. Timepoint: Zero, one month, two and six months after. Method of measurement: Visual Analog Scale(VAS).;The severity of symptoms and functional limitations. Timepoint: Zero, one month, two and six months after. Method of measurement: By using WOMAC questionnare.

Secondary

MeasureTime frame
Side effects. Timepoint: one day,two and four weeks after. Method of measurement: Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad hossein Taherian

Iran University of Medical Sciences

m.hossein.taherian76@gmail.com+98 21 4128 9221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026